Journal of Hematology & Oncology

Articles

Recent
Most accessed

Recent articles RSS

Review

Recent advances of bispecific antibodies in solid tumors

Shengnan Yu, Anping Li, Qian Liu, Xun Yuan, Hanxiao Xu, Dechao Jiao, Richard G. Pestell, Xinwei Han and Kongming Wu

Published on: 20 September 2017
Short report

Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study

Xinyang Liu, Shukui Qin, Zhichao Wang, Jianming Xu, Jianping Xiong, Yuxian Bai, Zhehai Wang, Yan Yang, Guoping Sun, Liwei Wang, Leizhen Zheng, Nong Xu, Ying Cheng, Weijian Guo, Hao Yu, Tianshu Liu…

Published on: 5 September 2017
Review

Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia

Mingxue Fan, Minghao Li, Lipeng Gao, Sicong Geng, Jing Wang, Yiting Wang, Zhiqiang Yan and Lei Yu

Published on: 29 August 2017
Research

Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

Eddy C. Hsueh, James R. DeBloom, Jonathan Lee, Jeffrey J. Sussman, Kyle R. Covington, Brooke Middlebrook, Clare Johnson, Robert W. Cook, Craig L. Slingluff Jr and Kelly M. McMasters

Published on: 29 August 2017
Review

Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia

Guoqing Wei, Jiasheng Wang, He Huang and Yanmin Zhao

Published on: 18 August 2017

View all articles

Most accessed articles RSS

Review

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

Gerhard J Molderings, Stefan Brettner, Jürgen Homann and Lawrence B Afrin

Published on: 22 March 2011
Review

The effects of β-glucan on human immune and cancer cells

Godfrey Chi-Fung Chan, Wing Keung Chan and Daniel Man-Yuen Sze

Published on: 10 June 2009
Review

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Xinyuan Li, Pu Fang, Jietang Mai, Eric T Choi, Hong Wang and Xiao-feng Yang

Published on: 25 February 2013
Review

Ibrutinib and novel BTK inhibitors in clinical development

Akintunde Akinleye, Yamei Chen, Nikhil Mukhi, Yongping Song and Delong Liu

Published on: 19 August 2013
Review

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies

Li Shi, Shaohua Chen, Lijian Yang and Yangqiu Li

Published on: 30 September 2013

View all articles

Aims and scope

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology.

Editor's quote

"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."

Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology

Experimental Hematology & Oncology

Submit your research to our companion journal, Experimental Hematology & Oncology

Research highlights

Journal of Hematology & Oncology is now publishing Research Highlights, commentaries on recently published work that place the new research in the context of the current literature.

Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer
Janice Lu

AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy
Jingjing Wu, Jiaping Fu, Mingzhi Zhang, Delong Liu

Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting—its impact on clinical practice
Gaurav Goel, Weijing Sun

Submit a manuscript

Impact Factor: 6.350